+61 2 9452 6666 how to order

Australian Biotechnologies was founded on research and development. Employing advanced biotechnologies and working with leading technology partners from around the world our goal is to make the most advanced Allograft offerings available to surgeons and their patients in Australia. The aim of our research and development has always been to ensure safety whilst improving clinical efficacy.

As a result of our efforts over many years, Australian Biotechnologies is now able to offer surgeons and their patient’s advanced CO2 treated portico-cancellous Allovance® Crunch, processed with our CO2 treatment. This technology sets a new standard for Allograft safety.

Our research and development is focused on using Australian science. Our projects include internal and external research (including universities and hospitals), case studies and clinical papers compiled and proven by Australian Science in an effort to expand the range and quality of graft materials.

Other ongoing research and development efforts include enhancing processing techniques and working toward the development of inductive Allografts in various forms.